This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sutton, T.J. Articles by Jones, H.B. Search for Related Content PubMed Articles by Sutton, T.J. Articles by Jones, H.B. Social Bookmarking                         What's this?

Red Cell Haemolysis Induced by SK&F 95018—a Combined Vasodilator and β-Adrenoceptor Antagonist

Department of Pathology and Toxicology, Smith Kline and French Research Ltd., The Frythe, Welwyn, Hertfordshire, AL6 9AR, UK

J.S.H. Luke

Department of Pathology and Toxicology, Smith Kline and French Research Ltd., The Frythe, Welwyn, Hertfordshire, AL6 9AR, UK

H.B. Jones

Department of Pathology and Toxicology, Smith Kline and French Research Ltd., The Frythe, Welwyn, Hertfordshire, AL6 9AR, UK

SK&F 95018, a potential antihypertensive agent with the combined properties of vasodilation and β-adrenoceptor antagonism, induced red urine when given intravenously to a dog. Further studies revealed that in the dog, SK&F 95018 treatment led to haemoglobinaemia, haemoglobinuria and a fall in the red blood cell count. The compound was therefore suspected of causing red cell haemolysis and this was confirmed using dog blood in an in vitro haemolysis test system. Oral administration of the compound to dogs gave no indication of haemolysis, but the animals lost large portions of their dose through vomiting and the lack of effect is therefore questionable. Rats, which have no vomit reflex, were treated orally and although no direct evidence of haemolysis was obtained (e.g. haemoglobinaemia), the presence of polychromasia suggested some loss of mature red blood cells had occurred. Rat blood was haemolysed in vitro by SK&F 95018. Human red cells were also used in the in vitro haemolysis test system and these, too, were lysed by the compound. The haemolysis was shown to be related to the structure of the compound itself rather than to its pharmacological effects and development of SK&F 95018 as an antihypertensive agent was abandoned. Electron microscopy indicated that SK&F 95018 induced alterations in the red cell membrane which led to shape change, characterized by discocyte to spherocyte transformation, and finally haemolysis. The mechanism of this effect remains under investigation.

Human & Experimental Toxicology, Vol. 7, No. 3, 243-248 (1988)
DOI: 10.1177/096032718800700302


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?